Skip to main content
Cancer Explained
Beginner 4 min readSource verified

What Does "Triple-Negative" Breast Cancer Mean?

Triple-negative means a breast cancer tests negative for estrogen receptors, progesterone receptors, and HER2. What that means for treatment options.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Last updated: 2026-07-12Next planned review: 2028-07-11

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute

The short answer

"Triple-negative" describes a breast cancer that tests negative for three receptors: estrogen receptor (ER), progesterone receptor (PR), and HER2. Because it lacks these targets, hormone therapy and HER2-targeted drugs generally don't work — so chemotherapy, and increasingly immunotherapy and other approaches, are the mainstays. It describes the cancer's biology, not its stage, and effective treatments exist.

  • Triple-negative = negative for ER, PR, and HER2 on testing.

  • Hormone therapy and HER2-targeted drugs usually aren't options because those targets are absent.

  • Chemotherapy is a mainstay; immunotherapy and other treatments may be options depending on the situation.

  • It describes biology, not stage — triple-negative cancers can be early or advanced.

Choose how you want to understand this

The full explanation.

Where you'll see this phrase

On a breast cancer pathology or biomarker report, after receptor testing. You may see "ER negative, PR negative, HER2 negative — triple-negative breast cancer (TNBC)."

What it means in plain language

Doctors test breast cancers for three features that can be targeted by treatment: estrogen receptor, progesterone receptor, and HER2. When all three are absent — "triple-negative" — the cancer doesn't have those particular targets.

Why it matters

The receptors matter because they're what certain treatments aim at. Without them, hormone therapy and HER2 drugs aren't expected to work. That's why triple-negative cancers are treated mainly with chemotherapy, and — depending on the situation — immunotherapy, targeted drugs for specific mutations, or clinical trials.

What it does not mean

  • It does not mean "untreatable." Effective treatments exist, and research is active.
  • It does not describe the stage. Triple-negative cancers can be caught early.

What context is still needed

Triple-negative is a biology label. Your full plan depends on stage, grade, genetic testing, and your overall health — all of which your oncologist puts together with you.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

Is triple-negative breast cancer always aggressive?

Triple-negative cancers can grow faster on average, but they vary a lot person to person. Stage, grade, and how the cancer responds to treatment all matter, and many people are treated successfully.

Why can't I take hormone therapy?

Hormone therapies work by blocking estrogen or progesterone signals. If the cancer is ER- and PR-negative, there's no receptor for those drugs to act on, so they aren't expected to help.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Plain-language definitions for the words on your report.

Look up another report term

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Source verified This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 9 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Does "Triple-Negative" Breast Cancer Mean?